Cullinan Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-12,340
| Closed | -$1.23M | – | 187 |
|
|
2019
Q3 | $1.23M | Hold |
12,340
| – | – | 0.09% | 120 |
|
|
2019
Q2 | $1.14M | Sell |
12,340
-1,920
| -13% | -$178K | 0.08% | 123 |
|
|
2019
Q1 | $1.35M | Sell |
14,260
-2,800
| -16% | -$264K | 0.1% | 124 |
|
|
2018
Q4 | $1.09M | Sell |
17,060
-53,555
| -76% | -$3.43M | 0.09% | 122 |
|
|
2018
Q3 | $6.32M | Buy |
70,615
+6,700
| +10% | +$600K | 0.46% | 65 |
|
|
2018
Q2 | $5.08M | Buy |
63,915
+8,090
| +14% | +$642K | 0.39% | 73 |
|
|
2018
Q1 | $4.98M | Sell |
55,825
-7,550
| -12% | -$674K | 0.38% | 77 |
|
|
2017
Q4 | $6.61M | Buy |
63,375
+1,107
| +2% | +$116K | 0.49% | 51 |
|
|
2017
Q3 | $9.08M | Sell |
62,268
-2,050
| -3% | -$299K | 0.7% | 41 |
|
|
2017
Q2 | $8.35M | Buy |
64,318
+2,000
| +3% | +$260K | 0.65% | 44 |
|
|
2017
Q1 | $7.75M | Buy |
62,318
+900
| +1% | +$112K | 0.63% | 45 |
|
|
2016
Q4 | $7.11M | Sell |
61,418
-647
| -1% | -$74.9K | 0.61% | 46 |
|
|
2016
Q3 | $6.49M | Buy |
62,065
+58
| +0.1% | +$6.06K | 0.55% | 46 |
|
|
2016
Q2 | $6.12M | Buy |
62,007
+11,800
| +24% | +$1.16M | 0.5% | 54 |
|
|
2016
Q1 | $5.03M | Buy |
50,207
+800
| +2% | +$80.1K | 0.43% | 67 |
|
|
2015
Q4 | $5.92M | Buy |
49,407
+3,000
| +6% | +$359K | 0.52% | 49 |
|
|
2015
Q3 | $5.02M | Sell |
46,407
-170
| -0.4% | -$18.4K | 0.46% | 54 |
|
|
2015
Q2 | $5.39M | Hold |
46,577
| – | – | 0.44% | 56 |
|
|
2015
Q1 | $5.37M | Buy |
+46,577
| New | +$5.37M | 0.42% | 54 |
|